Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...

With several drugs in use that inhibit the hepatitis B virus polymerases (nucleos(t)ide analogues (or NUCs)), some argue that new direct-acting antiviral drugs, and new NUCs in particular ...

Sharing injection supplies increases the risk of bloodborne infections such as HIV infection, hepatitis B virus infection, and hepatitis C virus infection. In addition, adulterants in drugs can ...

Tests for hepatitis B, hepatitis C virus, and HIV were also negative ... Magnetic resonance cholangiopancreatography (MRCP) did not show any signs of biliary tract obstruction on the 93rd day (Figures ...

The response of a series of patients with primary eosinophilic esophagitis to dilation is reported together with a description of a possibly pathognomonic sign: fragile esophageal mucosa ...

Grade III: severe—chronic persistent symptoms/and/or intermittent signs with corneal involvement or asymptomatic to mild symptoms with corneal pathognomonic signs. Grade IV: very severe—chronic ...

GUELPH, Ont. — Linamar Corp. says it has signed deals with the federal and Ontario governments that will see them come together to invest a combined $1.1 billion in automotive technology. The Ontario ...

And while their plans to sign the player on a pre-contract agreement remain ongoing, the Spanish giants are keen to thrash out a deal with Liverpool sooner having lodged an opening €20m (£16.8m ...

Los Angeles mysterious help sign: Officials are yet to comment on the images, but several theories have sprung up on X. A Los Angeles region near a shipping port has shot into the limelight after ...

New recommendations address advances in immunosuppressive therapies and highlight antiviral prophylaxis for high-risk patients. Study: AGA Clinical Practice Guideline on the Prevention and ...

Nearly 14 years after white-nose syndrome began devastating bat populations in New Brunswick, researchers see signs the fungus is receding and bats are becoming more resilient against the disease.